	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
S99-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S99-BMJ_2010_Apr_29_340_c1640	['ultraviolet radiation exposure during the first trimester would be expected to specifically INFLUENCE Vitamin D concentrations up to early in the second trimester, given that Vitamin D has a half life of one to two months.45in RECENT australian work, higher levels of ambient ultraviolet radiation were ASSOCIATED with higher Vitamin D concentrations at the population level with a lag of one and a half months.46\n\nPOSSIBLE mechanisms\nfirst trimester Vitamin D concentrations MIGHT be particularly IMPORTANT in the development of the Central Nervous System BECAUSE during Early Embryonic Development, Vitamin D receptors are Expressed in the Neuroepithelium and later in the Subventricular Zone.15myelination occurs later; EVEN in mid-Gestation (19-24 weeks) Cortical Axonal tracts are not yet myelinated,47with major myelination of several areas occurring as late as 29-39 weeks.48in addition, the in utero Development Of Immune central Tolerance occurs in the first trimester and Vitamin D has immunomodulating properties.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 303), ('INCOMPLETE_EVIDENCE', 415), ('INCOMPLETE_EVIDENCE', 476), ('IMPORTANT_CONSIDERATION', 498), ('PROBABLE_UNDERSTANDING', 557), ('ANOMALY_CURIOUS_FINDING', 723)]	8	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 326, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 534, 'central nervous system'), ('UBERON_0019248', 'early embryo', 572, 'early embryonic'), ('GO_0009790', 'embryo development', 578, 'embryonic development'), ('CHEBI_27300', 'vitamin D', 601, 'vitamin D'), ('GO_0010467', 'gene expression', 625, 'expressed'), ('UBERON_0034705', 'developing neuroepithelium', 642, 'neuroepithelium'), ('UBERON_0004922', 'postnatal subventricular zone', 675, 'subventricular zone'), ('GO_0007565', 'female pregnancy', 735, 'gestation'), ('UBERON_0001851', 'cortex', 759, 'cortical'), ('GO_0030424', 'axon', 768, 'axonal'), ('GO_0034102', 'erythrocyte clearance', 908, 'development of ... tolerance'), ('UBERON_0002405', 'immune system', 923, 'immune'), ('CHEBI_27300', 'vitamin D', 982, 'vitamin D')]
S84-PMC2582131	PMC2582131	11/2008	S84-PMC2582131	['the MAJOR sources of Vitamin D in the body are dietary Vitamin D intake and supplementation as well as Endogenous Production Of Vitamin D in the skin exposed to sunlight.']	[('IMPORTANT_CONSIDERATION', 4)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0009790', 'embryo development', 103, 'endogenous'), ('GO_0018240', 'protein S-linked glycosylation via cysteine', 114, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
S93-PMC2582131	PMC2582131	11/2008	S93-PMC2582131	['for instance, Endogenous Production Of Vitamin D In the Skin due to sun exposure is a MAJOR source of Plasma 25-[Oh] D. sun exposure could be positively CORRELATED with outdoor physical activity, a PROTECTIVE FACTOR for Insulin resistance and gdm[32]–[34].']	[('IMPORTANT_CONSIDERATION', 86), ('SUPERFICIAL_RELATIONSHIP', 153), ('SUPERFICIAL_RELATIONSHIP', 198)]	3	[('GO_0009790', 'embryo development', 14, 'endogenous'), ('GO_1902907', 'proteasome storage granule disassembly', 25, 'production of vitamin D in ... skin'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 102, 'plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 109, '25-[OH] D'), ('PR_000045358', 'insulin family protein', 220, 'insulin')]
S435-PMC3407995	PMC3407995	7/2012	S435-PMC3407995	['their RECOMMENDATION was 37.5–50 μg 1500–2000 iu) per day in Pregnant and Lactating women with Vitamin D deficiency [172].table 1includes RECOMMENDATIONS from various health agencies and governments around the world.Nutrients-04-00799-t001_table 1\n\ncaption (table-wrap): table 1\n\nVitamin D intake RECOMMENDATIONS during Pregnancy and Lactation.agency/governmentrecommendationuk—for the elderly, Pregnant & Lactating women [173]dietary reference values 10 µg/day (400 iu/day)uk department of health 2007—for Pregnant and Lactating women [45]10 µg/day (400 iu/day)uk national institute of health and clinical excellence guideline review panel 2007 [45]all women SHOULD BE informed about the IMPORTANCE for their own and their baby’s health of maintaining adequate Vitamin D stores during Pregnancy and whilst Breast feeding and may choose to take 400 iu/day.canadian paediatric society [45]50 μg/day (2000 iu/day) throughout Pregnancyfederal department of health canada [45]5 μg/day (200 iu/day) for Pregnant and Breast-feeding womeneuropean commission [45]10 μg/day (400 iu/day) during Pregnancyworld health organisation 2004 [45]5 μg/day (200 iu/day) during Pregnancythe institute of medicine us 2010 [172,174]15 μg/day (600 iu/day) in Pregnant and Lactating womenus Endocrine task force on Vitamin D 2011 [174]37.5–50 μg/day (1500–2000 iu) in Pregnant and Lactating women with Vitamin D deficiency.']	[('FUTURE_WORK', 6), ('FUTURE_WORK', 138), ('FUTURE_WORK', 297), ('FUTURE_WORK', 660), ('IMPORTANT_CONSIDERATION', 689)]	5	[('GO_0007565', 'female pregnancy', 61, 'pregnant'), ('GO_0007594', 'puparial adhesion', 74, 'lactating'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_33284', 'nutrient', 216, 'nutrients'), ('CHEBI_28384', 'vitamin K', 280, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 320, 'pregnancy'), ('GO_0007595', 'lactation', 334, 'lactation'), ('GO_0007565', 'female pregnancy', 395, 'pregnant'), ('GO_0007594', 'puparial adhesion', 406, 'lactating'), ('GO_0007565', 'female pregnancy', 507, 'pregnant'), ('GO_0007594', 'puparial adhesion', 520, 'lactating'), ('CHEBI_27300', 'vitamin D', 762, 'vitamin D'), ('GO_0007565', 'female pregnancy', 786, 'pregnancy'), ('UBERON_0000310', 'breast', 807, 'breast'), ('GO_0007565', 'female pregnancy', 923, 'pregnancyFederal'), ('GO_0007565', 'female pregnancy', 998, 'pregnant'), ('UBERON_0000310', 'breast', 1011, 'breast'), ('GO_0014065', 'phosphatidylinositol 3-kinase signaling', 1085, 'pregnancyWorld'), ('GO_0036240', 'septal periplasm', 1158, 'pregnancyThe'), ('GO_0007565', 'female pregnancy', 1236, 'pregnant'), ('GO_0007594', 'puparial adhesion', 1249, 'lactating'), ('GO_0009790', 'embryo development', 1267, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 1267, 'Endocrine'), ('CHEBI_28384', 'vitamin K', 1291, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1291, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1344, 'pregnant'), ('GO_0007594', 'puparial adhesion', 1357, 'lactating'), ('CHEBI_27300', 'vitamin D', 1378, 'vitamin D')]
S67-PMC3465343	PMC3465343	10/2012	S67-PMC3465343	['vad induced Skeletal abnormalities in neonatal Rats\nbecause Vitamin A is REQUIRED for Skeletal Development during Embryo Development, we also exmined the OTHER Skeletal System of neonatal Rats by the same anteroposterior radiography.']	[('IMPORTANT_CONSIDERATION', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 154)]	2	[('UBERON_0004288', 'skeleton', 12, 'skeletal'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 47, 'rats'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin A'), ('GO_0001501', 'skeletal system development', 86, 'skeletal development'), ('UBERON_0004288', 'skeleton', 86, 'skeletal'), ('GO_0009790', 'embryo development', 114, 'embryo development'), ('UBERON_0000922', 'embryo', 114, 'embryo'), ('UBERON_0001434', 'skeletal system', 160, 'skeletal system'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 188, 'rats')]
S126-PMC3465343	PMC3465343	10/2012	S126-PMC3465343	['the phenomenon that Gestational Vitamin A deficiency disrupts Embryonic Development HAS BEEN KNOWN for over 80 years.']	[('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 93)]	2	[('GO_0007565', 'female pregnancy', 20, 'gestational'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin A'), ('GO_0009790', 'embryo development', 62, 'embryonic development'), ('UBERON_0000922', 'embryo', 62, 'embryonic')]
S2-PMC3471827	PMC3471827	10/2012	S2-PMC3471827	['ttp and Vitamin E are ESSENTIAL for Productive Pregnancy in rodents, but their precise physiological ROLE in Embryogenesis is UNKNOWN.']	[('IMPORTANT_CONSIDERATION', 22), ('SUPERFICIAL_RELATIONSHIP', 101), ('FULL_UNKNOWN', 126)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin E'), ('GO_0007128', 'meiotic prophase I', 36, 'productive'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('GO_0009790', 'embryo development', 109, 'embryogenesis')]
S107-PMC3472720	PMC3472720	8/2012	S107-PMC3472720	['eae symptoms in the f2generation are equally increased IF it is either the f1mother or the f1father that has been Vitamin D-deprived during Embryogenesis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 55)]	1	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0009790', 'embryo development', 140, 'embryogenesis')]
S113-PMC3488410	PMC3488410	10/2012	S113-PMC3488410	['the Vitamin D deficiency MODEL APPEARS TO BE useful to study the IMPACT of Brain disturbances during Embryonic/fetal Development [127,128].']	[('INCOMPLETE_EVIDENCE', 25), ('ANOMALY_CURIOUS_FINDING', 31), ('SUPERFICIAL_RELATIONSHIP', 65)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('UBERON_0000955', 'brain', 75, 'brain'), ('GO_0009790', 'embryo development', 101, 'embryonic ... development'), ('UBERON_0000922', 'embryo', 101, 'embryonic')]
S24-PMC3651971	PMC3651971	5/2013	S24-PMC3651971	['introduction\nrisk for Cognitive and motor impairment begins in the Womb, where nutritional restrictions on Embryofetal Tissue growth, differentiation, development and Maturation MAY disturb growth, maturation and function of the Central Nervous System.1neural myelination and Synaptogenesis are underway before 24\u2005weeks’ Gestational age, Neural Tube Formation and Cell Migration are complete before the third Trimester of Pregnancy, and basic structures of the Brain formed before Birth.2as complex structures and functions extend as a cascade, disruptions to nascent systems by nutritional and OTHER insults CAN be amplified with age.3\nEmbryofetal Development is sensitive to Gestational deficiency in Vitamin A,4most EVIDENT in Animals by gross anomalies in Organ and Tissue Morphogenesis, development, structure and function.5–7Retinoic Acid, the oxidised Metabolite and transcriptional ligand of Vitamin A, Regulates the Expression of hox Genes that are essential in Neural Tube Formation,8the Development Of Neurons, and in Synaptic Signalling that UNDERLIES Learning and Memory.9–13developing neural Tissue in the Mouse is ESPECIALLY sensitive to variation in Retinoic Acid exposure near Parturition, a time analogous to the second Trimester of Human Gestation, when deficiency can induce behavioural problems and mild structural damage within the Limbic Cortex.14\nchronic dietary Vitamin A deficiency is common among Pregnant women in poor countries,1516leading TO concern that it MAY have adverse consequences for Cognitive and Motor Development Of the Fetus.']	[('INCOMPLETE_EVIDENCE', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 595), ('INCOMPLETE_EVIDENCE', 609), ('PROBABLE_UNDERSTANDING', 719), ('SUPERFICIAL_RELATIONSHIP', 1054), ('ANOMALY_CURIOUS_FINDING', 1129), ('QUESTION_ANSWERED_BY_THIS_WORK', 1469), ('INCOMPLETE_EVIDENCE', 1488)]	8	[('GO_0050890', 'cognition', 22, 'cognitive'), ('UBERON_0002396', 'vomer', 67, 'womb'), ('UBERON_0000922', 'embryo', 107, 'embryofetal'), ('UBERON_0000479', 'tissue', 119, 'tissue'), ('GO_0007618', 'mating', 167, 'maturation'), ('UBERON_0001017', 'central nervous system', 229, 'central nervous system'), ('GO_0007416', 'synapse assembly', 276, 'synaptogenesis'), ('GO_0007565', 'female pregnancy', 321, 'gestational'), ('GO_0042136', 'neurotransmitter biosynthetic process', 338, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 338, 'neural tube'), ('GO_0016477', 'cell migration', 364, 'cell migration'), ('GO_0009294', 'DNA mediated transformation', 409, 'trimester'), ('GO_0007565', 'female pregnancy', 422, 'pregnancy'), ('UBERON_0000955', 'brain', 461, 'brain'), ('GO_0007567', 'parturition', 481, 'birth'), ('GO_0009790', 'embryo development', 637, 'Embryofetal development'), ('UBERON_0000922', 'embryo', 637, 'Embryofetal'), ('GO_0007565', 'female pregnancy', 677, 'gestational'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 730, 'animals'), ('UBERON_0000062', 'organ', 760, 'organ'), ('GO_0048729', 'tissue morphogenesis', 770, 'tissue morphogenesis'), ('UBERON_0000479', 'tissue', 770, 'tissue'), ('CHEBI_52071', 'dextran', 828, '5'), ('CHEBI_24115', 'fuconate', 830, '7Retinoic acid'), ('CHEBI_39382', 'flufenoxuron', 859, 'metabolite'), ('CHEBI_27300', 'vitamin D', 900, 'vitamin A'), ('GO_0065007', 'biological regulation', 911, 'regulates'), ('GO_0010467', 'gene expression', 925, 'expression'), ('SO_0000704', 'gene', 943, 'genes'), ('GO_0042136', 'neurotransmitter biosynthetic process', 971, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 971, 'neural tube'), ('GO_0046697', 'decidualization', 998, 'development of neurons'), ('CL_0000540', 'neuron', 1013, 'neurons'), ('GO_0045202', 'synapse', 1029, 'synaptic'), ('GO_0099536', 'synaptic signaling', 1029, 'synaptic signalling'), ('GO_0007612', 'learning', 1064, 'learning'), ('GO_0007613', 'memory', 1077, 'memory'), ('UBERON_0000479', 'tissue', 1106, 'tissue'), ('NCBITaxon_10088', 'Mus <genus>', 1120, 'mouse'), ('CHEBI_26536', 'retinoic acid', 1166, 'retinoic acid'), ('GO_0019230', 'proprioception', 1194, 'parturition'), ('GO_0009294', 'DNA mediated transformation', 1238, 'trimester'), ('NCBITaxon_9606', 'Homo sapiens', 1251, 'human'), ('GO_0007565', 'female pregnancy', 1257, 'gestation'), ('UBERON_0016542', 'limbic cortex', 1354, 'limbic cortex'), ('CHEBI_27300', 'vitamin D', 1387, 'vitamin A'), ('GO_0007565', 'female pregnancy', 1424, 'pregnant'), ('GO_0050890', 'cognition', 1522, 'cognitive ...'), ('GO_0048870', 'cell motility', 1536, 'motor development of ... fetus')]
S65-PMC3659910	PMC3659910	1/2013	S65-PMC3659910	['methods are CURRENTLY available to quantify the CONTRIBUTION of Endogenous Vitamin D Synthesis resulting from sun exposure, BUT SERIOUS LIMITATIONS REMAIN in ACCURATELY ESTIMATING dietary Vitamin D intake BECAUSE of the INCOMPLETENESS of Nutrient databases for both Vitamin D-fortified Food and Vitamin D supplements.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 48), ('PROBLEM_COMPLICATION', 124), ('IMPORTANT_CONSIDERATION', 128), ('PROBLEM_COMPLICATION', 136), ('INCOMPLETE_EVIDENCE', 148), ('SUPERFICIAL_RELATIONSHIP', 158), ('INCOMPLETE_EVIDENCE', 169), ('PROBLEM_COMPLICATION', 205), ('INCOMPLETE_EVIDENCE', 220)]	10	[('GO_0009790', 'embryo development', 64, 'endogenous'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 75, 'vitamin D synthesis'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_33284', 'nutrient', 238, 'nutrient'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_33290', 'food', 286, 'food'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
S48-PMC3702245	PMC3702245	6/2013	S48-PMC3702245	['Vitamin D HAS BEEN SHOWN to upregulate Endogenous Synthesis Of Cathelicidin, a potent Antimicrobial peptide, in response to Microbial Invasion, via activation of toll-like receptors on microphages and Monocytes.6,24given that Antimicrobial peptides provide rapid Defense against invading pathogens, it is PLAUSIBLE that Vitamin D plays a ROLE in host defense against infections in both mother and offspring.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 305), ('SUPERFICIAL_RELATIONSHIP', 338)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0009790', 'embryo development', 39, 'endogenous'), ('GO_0007608', 'sensory perception of smell', 50, 'synthesis of ...'), ('CHEBI_3364', 'Canthiumine', 63, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 63, 'cathelicidin'), ('CHEBI_65381', 'albizoside C', 86, 'antimicrobial'), ('NCBITaxon_10088', 'Mus <genus>', 124, 'microbial'), ('GO_0007586', 'digestion', 134, 'invasion'), ('CL_0000576', 'monocyte', 201, 'monocytes'), ('CHEBI_65381', 'albizoside C', 226, 'antimicrobial'), ('GO_0006952', 'defense response', 263, 'defense'), ('CHEBI_27300', 'vitamin D', 320, 'vitamin D')]
S99-PMC3827489	PMC3827489	10/2013	S99-PMC3827489	['in 2011, the u.s. Endocrine task force on Vitamin D REPORTED that 600 iu/day MAY not be sufficient to correct Vitamin D deficiency in Pregnant and Lactating women, and THEREFORE SUGGESTED 1,500-2,000 iu/day for Pregnant and Lactating women with Vitamin D deficiency75).']	[('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 168), ('INCOMPLETE_EVIDENCE', 178)]	4	[('GO_0009790', 'embryo development', 18, 'Endocrine'), ('CHEBI_28384', 'vitamin K', 42, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0007565', 'female pregnancy', 134, 'pregnant'), ('GO_0007594', 'puparial adhesion', 147, 'lactating'), ('GO_0007565', 'female pregnancy', 211, 'pregnant'), ('GO_0007594', 'puparial adhesion', 224, 'lactating'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D')]
S69-PMC4071151	PMC4071151	6/2014	S69-PMC4071151	['Nutrients such as Vitamins A, b6, b12 and Folic Acid and zinc AFFECT Embryogenesis and a deficiency in any of these elements MAY BE RELATED to spontaneous abortion failure and to a spectrum of Neurodevelopmental disorders [16].']	[('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 125), ('SUPERFICIAL_RELATIONSHIP', 132)]	3	[('CHEBI_33284', 'nutrient', 0, 'Nutrients'), ('CHEBI_27300', 'vitamin D', 18, 'vitamins A'), ('CHEBI_30751', 'formic acid', 42, 'folic acid'), ('GO_0009790', 'embryo development', 69, 'embryogenesis'), ('GO_0007399', 'nervous system development', 193, 'neurodevelopmental')]
S10-PMC4488777	PMC4488777	5/2015	S10-PMC4488777	['ON THE OTHER HAND, EVIDENCE-BASED research DID NOT prove a significant DIFFERENCE so far in Ovulation stimulation or Embryo Development depending on Vitamin D level.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71)]	4	[('GO_0030728', 'ovulation', 92, 'ovulation'), ('GO_0009790', 'embryo development', 117, 'embryo development'), ('UBERON_0000922', 'embryo', 117, 'embryo'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
S4-PMC4969253	PMC4969253	8/2016	S4-PMC4969253	['introduction: Retinoic Acid, a CRUCIAL signal for Formation Of the Embryonic Lung\nCLASSIC STUDIES in multiple species, including Hamsters, Rats, and Mice, HAVE SHOWN major pleiotropic EFFECTS of maternal dietary Vitamin A deprivation in Embryonic Development.']	[('IMPORTANT_CONSIDERATION', 31), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	[('CHEBI_26536', 'retinoic acid', 14, 'retinoic acid'), ('GO_0001703', 'gastrulation with mouth forming first', 50, 'formation of ... lung'), ('UBERON_0000922', 'embryo', 67, 'embryonic'), ('UBERON_0002048', 'lung', 77, 'lung'), ('NCBITaxon_33208', 'Metazoa', 129, 'hamsters'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 139, 'rats'), ('NCBITaxon_10088', 'Mus <genus>', 149, 'mice'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin A'), ('GO_0009790', 'embryo development', 237, 'embryonic development'), ('UBERON_0000922', 'embryo', 237, 'embryonic')]
S13-PMC5014971	PMC5014971	8/2016	S13-PMC5014971	['the geographic expansion of humanity, the modern environment, and medical CONCERNS over the sequela of extensive sun exposure (e.g., melanoma) have created conditions where for much of modern humanity Endogenous Vitamin D Production is LIKELY far below that of our ancestors.']	[('IMPORTANT_CONSIDERATION', 74), ('PROBABLE_UNDERSTANDING', 236)]	2	[('GO_0009790', 'embryo development', 201, 'endogenous'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 212, 'vitamin D production')]
S120-PMC5084016	PMC5084016	10/2016	S120-PMC5084016	['the Endogenous Synthesis Of Vitamin D requires exposure to ultraviolet radiation with a wavelength between 290 and 315 nm, and is INFLUENCED by several FACTORS, RELATED to both the Individual’s characteristics (such as sex and phenotype, weight), and environmental factors (the degree of physical activity, latitude, season, time of exposure to sunlight, pollution, use of sunscreens and supplements).']	[('SUPERFICIAL_RELATIONSHIP', 130), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 161)]	3	[('GO_0009790', 'embryo development', 4, 'endogenous'), ('GO_0030474', 'spindle pole body duplication', 15, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 36, 'D'), ('NCBITaxon_1', 'root', 181, 'individual')]
S14-PMC5264377	PMC5264377	7/2016	S14-PMC5264377	['Humans obtain their daily levels of Vitamin D MAINLY by Endogenous Biosynthesis induced by exposure to ultraviolet b (uvb) radiation, in concert with a small CONTRIBUTION from the Intake of different Food sources.']	[('PROBABLE_UNDERSTANDING', 46), ('SUPERFICIAL_RELATIONSHIP', 158)]	2	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Humans'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0009790', 'embryo development', 56, 'endogenous'), ('GO_0009057', 'macromolecule catabolic process', 67, 'biosynthesis'), ('GO_0007631', 'feeding behavior', 180, 'intake'), ('CHEBI_33290', 'food', 200, 'food')]
S159-PMC5706533	PMC5706533	11/2017	S159-PMC5706533	['the INTERPRETATION of Micronutrient intervention trials, HOWEVER, is COMPLEX BECAUSE all Individuals have some Vitamin D intake or Endogenous production.35the EFFECT of a given dose depends on the difference between the intervention and control doses (or the difference in mean 25(Oh)D in the intervention versus control group at/near delivery) as well as baseline Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 57), ('DIFFICULT_TASK', 69), ('PROBABLE_UNDERSTANDING', 77), ('SUPERFICIAL_RELATIONSHIP', 159)]	6	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 22, 'micronutrient'), ('NCBITaxon_1', 'root', 89, 'individuals'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0009790', 'embryo development', 131, 'endogenous'), ('CHEBI_71657', 'versiconol acetate', 278, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 278, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D')]
S32-PMC5941617	PMC5941617	5/2018	S32-PMC5941617	['caption (table-wrap): table 2\n\ndefinition of Vitamin D status according to several societies and organizations in the last 10\xa0yearssociety/organizationyearsevere deficiencydeficiencyinsufficiencysufficiency/adequacycanadian pediatric society [8]2007–<\u2009 10\xa0ng/ml10–29\xa0ng/ml≥ 30\xa0ng/mllawson wilkins pediatric Endocrine society [9]2008<\u2009 5\xa0ng/ml5–14\xa0ng/ml15–19\xa0ng/ml≥ 20\xa0ng/mlinstitute of medicine [10]2011–<\u2009 12\xa0ng/ml12–20\xa0ng/mla≥ 20\xa0ng/mlthe Endocrine society [11]2011–<\u2009 20\xa0ng/ml21–29\xa0ng/ml≥ 30\xa0ng/mlbritish paediatric and adolescent bone group [12]2012–<\u200910\xa0ng/ml10–19\xa0ng/ml≥ 20\xa0ng/mlfrench society of paediatrics [13]2012–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlasociación espanola de pediatría (spain) [14]2012–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlfederal commission for nutrition (switzerland) [15]2012<\u200910\xa0ng/ml<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlnordic nutrition recommendations [16]2012–<\u2009 12\xa0ng/ml12–20\xa0ng/ml≥ 20\xa0ng/mlgerman nutrition society [17]2012–––≥ 20\xa0ng/mlhealth council of the netherlands [18]2012–––≥ 12\xa0ng/mleuropean society for paediatric gastroenterology hepatology and nutrition [19]2013<\u200910\xa0ng/ml<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlcentral europe [20]2013–< 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlsociety for adolescent health and medicine [21]2013–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlaustralia/new zealand [22]2013<\u2009 5\xa0ng/ml5–11\xa0ng/ml12–19\xa0ng/ml≥ 20\xa0ng/mlamerican academy of pediatrics [23]2014–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mljapanese society for bone and Mineral research, japan Endocrine societyb[24]2015–<\u2009 20\xa0ng/ml––scientific advisory committee on nutrition [25]2016–––≥ 10\xa0ng/mleuropean Food safety authority [26]2016–––≥ 20\xa0ng/mlunited arab emirates [27]2016–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlglobal consensus for rickets [28]2016–<\u2009 12\xa0ng/ml12–19\xa0ng/ml≥ 20\xa0ng/mljapanese society for bone and Mineral research, japan Endocrine societyc[29]2017–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mleuropean academy of pediatrics [30]2017definition of Vitamin D status is UNCLEAR DUE TO a lack OF consensus\navitamin D inadequacy\nbdiagnostic criteria for rickets\ncassessment criteria for Vitamin D deficiency/insufficiency (authors REPORTED that DIFFERENT criteria MAY BE needed for children)\nsevere Vitamin D deficiency is DEFINED as 25(Oh)d levels <\u200910\xa0ng/ml by SEVERAL authors and societies BECAUSE the risk of rickets is high below this cut-off also in presence of an adequate Calcium intake [31–33] (see chapter “nutritional rickets”).']	[('FULL_UNKNOWN', 1894), ('PROBLEM_COMPLICATION', 1902), ('ANOMALY_CURIOUS_FINDING', 1916), ('ANOMALY_CURIOUS_FINDING', 1916), ('INCOMPLETE_EVIDENCE', 2053), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2067), ('INCOMPLETE_EVIDENCE', 2086), ('PROBABLE_UNDERSTANDING', 2145), ('INCOMPLETE_EVIDENCE', 2185), ('PROBABLE_UNDERSTANDING', 2215)]	10	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 307, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 441, 'Endocrine'), ('CHEBI_46662', 'mineral', 1396, 'Mineral'), ('GO_0009790', 'embryo development', 1420, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 1420, 'Endocrine'), ('CHEBI_33290', 'food', 1533, 'Food'), ('CHEBI_46662', 'mineral', 1738, 'Mineral'), ('GO_0009790', 'embryo development', 1762, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 1762, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 1874, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1938, 'D'), ('CHEBI_27300', 'vitamin D', 2009, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2121, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 2156, '25(OH)'), ('CHEBI_22313', 'alkaline earth metal atom', 2302, 'calcium')]
S109-PMC5941617	PMC5941617	5/2018	S109-PMC5941617	['caption (table-wrap): table 5\n\ndietary reference values of Vitamin D in infants, children, and adolescents as PROPOSED by various organizations and societiesorganization/societyyearcountry/countriesdietary reference value for Vitamin D0–12\xa0months, iu/day1–18\xa0years, iu/dayeuropean Food safety authority [26]2016europeai400 (7–11\xa0months)600 (1–17\xa0years)scientific advisory committee on nutrition [25]2016united kingdomsafe intake (<\u20094\xa0years)340–400400rni (4–18\xa0years)nordic nutrition recommendations [16]2012denmark, finland, iceland, norway, sweden, faroe islands, greenland, åland islandsri400400german nutrition society [17]2012germany, austria, switzerlandai400 (infants)800a(children)health council of the netherlands [18]2012the netherlandsai400400italian society of nutrition [89]2012italyai (<\u2009 12\xa0months)400 (6–12\xa0months)600pri (1–18\xa0years)institute of medicine [10]2011north america, canadaai (<\u2009 12\xa0months)400600rda (1–18\xa0years)the Endocrine society [11]2011worldwidedaily requirementb400–1000600–1000\nai adequate intake, the average observed daily level of Intake by a population group of apparently healthy People that is ASSUMED to be adequate\nsafe intake , a level or range of intakes considered to pose no risk of deficiency and below a level where there is a risk of undesirable EFFECTS\nrni reference Nutrient intake, the amount of a Nutrient that is LIKELY to meet the needs of 97.5% of the population\nri recommended intake, the amount of a Nutrient that meets the known REQUIREMENT and maintains good nutritional status among practically all (97–98%) healthy Individuals in a particular Life Stage or gender group\npri population reference intake, the level of Nutrient intake sufficient to satisfy the needs of ALMOST all (97.5%) healthy subjects in one specific population group\nrda recommended dietary allowance, the estimated intake capable of satisfying the needs of 97.5% of the population\naadequate intake with missing Endogenous Synthesis Of Vitamin D\nbrecommended REQUIREMENTS for subjects at risk of Vitamin D deficiency\nin accordance with the european society for paediatric gastroenterology hepatology and nutrition [espghan] [19] and the european academy of pediatrics [30], we endorsed tolerable upper intake levels of Vitamin D proposed by efsa in 2012 (1000\xa0iu/day for infants: 2000\xa0iu/day for children ages 1 to 10\xa0years; 4000\xa0iu/day for children and adolescents ages 11 to 17\xa0years) [90].']	[('INCOMPLETE_EVIDENCE', 110), ('PROBABLE_UNDERSTANDING', 1134), ('SUPERFICIAL_RELATIONSHIP', 1295), ('PROBABLE_UNDERSTANDING', 1367), ('IMPORTANT_CONSIDERATION', 1488), ('ANOMALY_CURIOUS_FINDING', 1729), ('IMPORTANT_CONSIDERATION', 1990)]	7	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 226, 'vitamin D0'), ('PR_000017299', 'VIP peptides', 226, 'vitamin D0'), ('CHEBI_33290', 'food', 281, 'Food'), ('UBERON_0005063', 'left ventricular compact myocardium', 942, 'Endocrine'), ('GO_0007631', 'feeding behavior', 1068, 'intake'), ('NCBITaxon_10088', 'Mus <genus>', 1119, 'people'), ('CHEBI_33284', 'nutrient', 1317, 'Nutrient'), ('CHEBI_33284', 'nutrient', 1350, 'nutrient'), ('CHEBI_33284', 'nutrient', 1458, 'nutrient'), ('NCBITaxon_1', 'root', 1577, 'individuals'), ('UBERON_0000105', 'life cycle stage', 1605, 'life stage'), ('CHEBI_33284', 'nutrient', 1678, 'nutrient'), ('GO_0009790', 'embryo development', 1943, 'endogenous'), ('GO_0030474', 'spindle pole body duplication', 1954, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 1967, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 1975, 'D'), ('CHEBI_27300', 'vitamin D', 2027, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2250, 'vitamin D')]
